Group Interpersonal Psychotherapy for Depressed Adolescents in School-based Clinics
|ClinicalTrials.gov Identifier: NCT00270244|
Recruitment Status : Completed
First Posted : December 26, 2005
Last Update Posted : December 30, 2011
|Condition or disease||Intervention/treatment||Phase|
|Depression||Behavioral: Group interpersonal psychotherapy for depressed adolescents (IPT-AG) Behavioral: Treatment as usual (TAU)||Phase 2|
Depression is a serious medical condition. It occurs in people of all ages, but only in the past two decades has depression in children and adolescents been taken seriously. Children and adolescents with depression may exhibit such behaviors as pretending to be sick, refusing to go to school or getting in trouble at school, clinging to a parent or worrying that the parent may die, sulking, or acting in a negative or grouchy manner. A previous study demonstrated that, when administered by clinicians in school-based clinics, individual interpersonal psychotherapy is effective in reducing depressive symptoms and improving global and social functioning. This study will assess the effectiveness of group interpersonal psychotherapy (IPT-AG) versus treatment as usual (TAU) in improving depressive symptoms of adolescents in school-based health clinics.
Participants in this 16-week single-blind study will be randomly assigned to receive either IPT-AG or TAU in a school-based clinic. Participants assigned to receive IPT-AG will attend two to three, 40-minute individual pre-group sessions, followed by 12, 90-minute group therapy sessions and two additional individual sessions—one midway through the group sessions and another upon completion of group therapy. TAU will consist of counseling sessions as regularly conducted by the school clinic social worker and/or referral to another agency. Study visits will occur at baseline and Weeks 4, 8, 12, and 16, or upon early termination. At the end of 16 weeks, participants assigned to receive IPT-AG will continue in a maintenance program in which they will receive IPT-AG once a month for an additional 6 months. All participants will also be assessed 6 and 12 months post-treatment to measure depressive symptoms, global and social functioning, satisfaction with care, and utilization of other services.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||16 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Care Provider, Outcomes Assessor)|
|Official Title:||Group Interpersonal Psychotherapy for Depressed Adolescents (IPT-AG) in School-based Clinics|
|Study Start Date :||December 2005|
|Primary Completion Date :||January 2008|
|Study Completion Date :||January 2008|
Active Comparator: 1
Participants will receive treatment as usual
Behavioral: Treatment as usual (TAU)
TAU will consist of counseling sessions as regularly conducted by the school clinic social worker and/or referral to another agency.
Participants will receive group interpersonal psychotherapy for depressed adolescents
Behavioral: Group interpersonal psychotherapy for depressed adolescents (IPT-AG)
Participants assigned to IPT-AG will attend two to three, 40-minute individual pre-group sessions, followed by 12, 90-minute group therapy sessions and two additional individual sessions—one midway through the group sessions and another upon completion of group therapy. Sessions will focus on problems in interpersonal relationships.
- Depressive symptoms as measured by the Hamilton Rating Scale for Depression (HRSD) and the Center for Epidemiological Studies-Depression Scale (CES-D) [ Time Frame: Measured at Month 18 ]
- Overall impairment, as measured by the Global Assessment Scale for Children (C-GAS) [ Time Frame: Measured at Month 18 ]
- Social functioning, as measured by the Social Adjustment Scale-Self-report (SAS-SR) [ Time Frame: Measured at Month 18 ]
- Short Acculturation Scale for Hispanics, CES-D, HRSD, C-GAS, Clinical Global Improvement, Inventory of Parent and Peer Attachment, Family Adaptation and Cohesions Evaluation Scales III, and the Penn Helping Alliance Questionnaire-Revised [ Time Frame: Measured at Month 18 ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00270244
|Principal Investigator:||Laura H. Mufson, PhD||New York State Psychiatric Institute-Columbia University College of Physicians and Surgeons|